Meridian Bioscience's Bioline Unit to Directly Market Products in Australia
August 23, 2011
Meridian Bioscience's Bioline Unit to Directly Market Products in Australia
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products
January 24, 2013 / PCR Insider - Meridian Bioscience NAAT for Group A Strep Shines in Multicenter Clinical Study
March 7, 2013 / PCR Insider - Dx Focus: Meridian Bioscience Ends Beta Trials for CT, NG Assays
December 13, 2012 / PCR Insider - Dx Focus: FDA Approves Meridian Bioscience Group B Strep Test; Hologic Cervista HTA System
December 15, 2011 / PCR Insider - Despite 12 Percent Drop in Q1 Sales, Meridian Bioscience Maintains Positive FY '11 Outlook
January 20, 2011 / PCR Insider